BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29415363)

  • 21. Weekly oral methotrexate therapy: raise awareness of fatal dosing errors.
    Prescrire Int; 2013 May; 22(138):126. PubMed ID: 23819175
    [No Abstract]   [Full Text] [Related]  

  • 22. Methotrexate nephrotoxicity: Novel treatment, new approach.
    Iqbal S; Armaghani A; Aiyer R; Kazory A
    J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation of methotrexate with or without a test dose: A retrospective toxicity study.
    Herrmann T; Buhnerkempe M; Wilson ML
    J Am Acad Dermatol; 2019 Apr; 80(4):1160-1162. PubMed ID: 30562566
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe complications after high-dose methotrexate treatment.
    Takami M; Kuniyoshi Y; Oomukai T; Ishida T; Yamano Y
    Acta Oncol; 1995; 34(5):611-2. PubMed ID: 7546826
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate-induced status epilepticus.
    Naing A; Luong D; Extermann M
    Am J Hematol; 2005 Sep; 80(1):35-7. PubMed ID: 16138356
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose methotrexate-induced bullous variant of acral erythema.
    Hellier I; Bessis D; Sotto A; Margueritte G; Guilhou JJ
    Arch Dermatol; 1996 May; 132(5):590-1. PubMed ID: 8624164
    [No Abstract]   [Full Text] [Related]  

  • 27. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
    Womer RB
    Pediatr Blood Cancer; 2010 Dec; 55(7):1250-1. PubMed ID: 20981687
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute methotrexate toxicity presenting with bullous lesions: an unusual presentation.
    Sanke S; Yadav P; Chander R; Chandra J
    Eur J Clin Pharmacol; 2017 Apr; 73(4):515-516. PubMed ID: 27975132
    [No Abstract]   [Full Text] [Related]  

  • 29. Effective eradication of oral verrucous carcinoma with continuous intraarterial infusion chemotherapy.
    Wu CF; Chen CM; Shen YS; Huang IY; Chen CH; Chen CY; Shieh TY; Sheen MC
    Head Neck; 2008 May; 30(5):611-7. PubMed ID: 18098309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hypokalemic tetraparesis induced by intravenous methotrexate.
    Thuss-Patience PC; Peters U; Jurkat-Rott K; Pink D; Kretzschmar A; Dörken B; Reichardt P
    J Clin Oncol; 2003 May; 21(9):1896-7. PubMed ID: 12721279
    [No Abstract]   [Full Text] [Related]  

  • 31. Acral erythema with oral methotrexate in a child.
    Varela CR; McNamara J; Antaya RJ
    Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 33. Ommaya reservoir "off-duty" causing major late-onset complications in a child with medulloblastoma.
    Walker JH; Hackenberg A; Bozinov O; Berger C; Scheer I; Grotzer MA; Gerber NU
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27905687
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.
    Bruijn MS; Horváth B; van Voorst Vader PC; Willemze R; Vermeer MH
    Br J Dermatol; 2015 Nov; 173(5):1319-22. PubMed ID: 25998985
    [No Abstract]   [Full Text] [Related]  

  • 36. Methotrexate-induced periorbital radiation recall.
    Kiel PJ; Jones KL
    Ann Pharmacother; 2011 Jan; 45(1):133. PubMed ID: 21205951
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract]   [Full Text] [Related]  

  • 38. Sclerosing encapsulating peritonitis and methotrexate.
    Sachdev A; Usatoff V; Thaow C
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):58-9. PubMed ID: 16441697
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 40. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
    Tsao TF; Chao YH
    Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.